Sign in
Australia's de facto biosimilar patent dance: a comparison with the United States' BPCIA
Journal article   Peer reviewed

Australia's de facto biosimilar patent dance: a comparison with the United States' BPCIA

Teddy Henriksen
European Intellectual Property Review, Vol.42(7), pp.406-413
2020

Abstract

Comparative Law Australia biosimilars patents United States
This article examines two different approaches to the exchange of information in biologic patent disputes: the legislative approach in the United States’ BPCIA and the nonlegislative approach in Australia, which is based primarily on the rules of evidence. Perhaps a mix of these approaches is most efficient: a mandatory exchange (as in Australia) prior to the commencement of litigation (as in the United States).

Details

Metrics

81 Record Views